Type II restriction modification system in Ureaplasma parvum OMC-P162 strain.
Ureaplasma parvum serovar 3 strain, OMC-P162, was isolated from the human placenta of a preterm delivery at 26 weeks' gestation. In this study, we sequenced the complete genome of OMC-P162 and compared it with other serovar 3 strains isolated from patients with different clinical conditions. Te...
Main Authors: | Heng Ning Wu, Yukiko Nakura, Michinobu Yoshimura, Ourlad Alzeus Gaddi Tantengco, Makoto Nomiyama, Toshimitsu Takayanagi, Tomio Fujita, Kiyoshi Yasukawa, Itaru Yanagihara |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2018-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC6191088?pdf=render |
Similar Items
-
Co-infection of human papillomavirus and other sexually transmitted bacteria in cervical cancer patients in the Philippines
by: Ourlad Alzeus G. Tantengco, et al.
Published: (2022-04-01) -
Exosomes from Ureaplasma parvum-infected ectocervical epithelial cells promote feto-maternal interface inflammation but are insufficient to cause preterm delivery
by: Ourlad Alzeus G. Tantengco, et al.
Published: (2022-08-01) -
Comparative genome analysis of 19 <it>Ureaplasma urealyticum</it> and <it>Ureaplasma parvum</it> strains
by: Paralanov Vanya, et al.
Published: (2012-05-01) -
Susceptibility and Antimicrobial Resistance of Genital Ureaplasma Parvum
by: Ghofran Kadhim Al-khafaji
Published: (2017-09-01) -
Prevalence of Ureaplasma parvum in the area of Prato, Italy
by: Tamara Brunelli, et al.
Published: (2015-06-01)